4.8 Article

Extracellular Vesicle-Encapsulated Adeno-Associated Viruses for Therapeutic Gene Delivery to the Heart

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Chemistry, Multidisciplinary

Endothelial Retargeting of AAV9 In Vivo

Tarik Bozoglu et al.

Summary: The study demonstrates a method of retargeting adeno-associated viruses (AAVs) to endothelial cells by coating them with second-generation polyamidoamine dendrimers (G2) linked to endothelial-affine peptides (CNN). This approach improves gene transfer efficiency, potentially enabling applications in vascular and atherosclerosis models.

ADVANCED SCIENCE (2022)

Review Biochemistry & Molecular Biology

Journey to the Center of the Cell: Tracing the Path of AAV Transduction

Bijay P. Dhungel et al.

Summary: With the increasing approval of AAV-based gene therapies for human use, understanding vector-host interactions becomes crucial. Advances in genome-wide genetic screening tools have enabled a clearer picture of AAV-host interactions, providing insights into the viral life cycle and potential novel strategies to overcome current limitations of AAV-based vectors. This summary outlines the current understanding of the stages in the journey of the vector and the roles of recently identified host factors.

TRENDS IN MOLECULAR MEDICINE (2021)

Review Cardiac & Cardiovascular Systems

Targeted delivery of therapeutic agents to the heart

Susmita Sahoo et al.

Summary: In this review, strategies for overcoming barriers and delivering therapeutic materials to the heart, including the use of adeno-associated viruses and exosomes, are discussed with a focus on modifying gene expression.

NATURE REVIEWS CARDIOLOGY (2021)

Review Biochemistry & Molecular Biology

Intracellular trafficking of adeno-associated virus (AAV) vectors: challenges and future directions

Jalish M. Riyad et al.

Summary: Recombinant adeno-associated virus has become the most popular gene therapy vector in the last two decades, with higher doses increasing the risk of adverse events. FDA has recently approved AAV gene therapy for two rare genetic disorders, highlighting the need for better vectors to achieve therapeutic levels with lower doses. The review discusses cellular roadblocks that AAV must overcome and recent advancements in AAV biology that can improve vector performance for safer gene therapy.

GENE THERAPY (2021)

Article Multidisciplinary Sciences

The membrane associated accessory protein is an adeno-associated viral egress factor

Zachary C. Elmore et al.

Summary: The membrane-associated accessory protein (MAAP) is identified as a novel viral egress factor that promotes the secretion of AAV serotypes. MAAP contains a cationic amphipathic domain critical for AAV secretion. Restoring MAAP expression can rescue the secretion defect in various AAV serotypes with mutated start sites.

NATURE COMMUNICATIONS (2021)

Review Cell Biology

The exosome journey: from biogenesis to uptake and intracellular signalling

Sonam Gurung et al.

Summary: Exosomes have vast potential in clinical applications, and understanding their biology is crucial. The processes of exosome biogenesis, transport, and uptake involve numerous influencing factors.

CELL COMMUNICATION AND SIGNALING (2021)

Article Multidisciplinary Sciences

Quantitative characterization of extracellular vesicle uptake and content delivery within mammalian cells

Emeline Bonsergent et al.

Summary: A quantitative method was developed to investigate the release of extracellular vesicle contents, indicating a requirement for endosomal acidification and potential involvement of membrane fusion.

NATURE COMMUNICATIONS (2021)

Article Biochemistry & Molecular Biology

Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species

Mohammadsharif Tabebordbar et al.

Summary: Evolved capsid variants of AAVs show enhanced potency and therapeutic efficacy for delivering genetic modifiers to muscle tissues, surpassing naturally occurring AAV capsids in mouse models of genetic muscle disease. These engineered vectors demonstrate conserved efficacy across different mouse strains, cynomolgus macaques, and human primary myotubes, indicating a promising approach for gene therapy.
Article Biotechnology & Applied Microbiology

Neutralizing Antibody Evasion and Transduction with Purified Extracellular Vesicle-Enveloped Adeno-Associated Virus Vectors

Ming Cheng et al.

Summary: Adeno-associated virus (AAV) can associate with extracellular vesicles (EVs) to enhance transduction in vivo and evade neutralizing antibodies. Purification of exo-AAV using density gradient method improves resistance to antibodies and allows for more efficient gene delivery, potentially providing insights into the mechanism of AAV incorporation into EVs.

HUMAN GENE THERAPY (2021)

Review Pharmacology & Pharmacy

Delivering AAV to the Central Nervous and Sensory Systems

Cole W. Peters et al.

Summary: Gene therapy is becoming more important in treating genetic diseases, especially Mendelian disorders. The development of new viral vectors has increased the options for treatment. This review provides an overview of gene therapies in the brain, ear, and eye, emphasizing the optimal approaches depending on cell type and transgene.

TRENDS IN PHARMACOLOGICAL SCIENCES (2021)

Review Virology

Adeno-Associated Virus (AAV) Gene Delivery: Dissecting Molecular Interactions upon Cell Entry

Edward E. Large et al.

Summary: Human gene therapy has advanced significantly from the concept in the 20th century to a reality in the 21st century, with recombinant Adeno-Associated Virus (rAAV) being a major gene therapy vector. Research is continuously working on improving the safety and efficacy of rAAV through various AAV capsid modification strategies, focusing on factors such as neutralizing antibodies and receptor binding to enhance transduction efficiency. Advances in understanding molecular interactions during rAAV cell entry, in combination with improved capsid modulation strategies, will lead to the design of safer and more efficient rAAV gene therapy vectors.

VIRUSES-BASEL (2021)

Article Medicine, Research & Experimental

Optimization of AAV6 transduction enhances site-specific genome editing of primary human lymphocytes

Geoffrey L. Rogers et al.

Summary: By optimizing ex vivo culture conditions, the study demonstrates that using a high concentration of AAV6 for a short transduction time combined with electroporation can improve genome editing rates in human CD4+ T cells and B cells, reducing cellular toxicity and decreasing the amount of AAV6 required.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2021)

Article Cell Biology

AAV-Containing Exosomes as a Novel Vector for Improved Gene Delivery to Lung Cancer Cells

Bin Liu et al.

Summary: The study developed a novel strategy to produce and purify AAV-containing exosomes (AAVExo) from AAV-packaging HEK 293T cells. The AAVExo improved gene transfer efficiency in lung cancer cell lines compared to conventional AAV vectors, and showed remarkable resistance to antibody neutralization in vitro and in a lung cancer xenograft rodent model.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Cell Biology

MIFlowCyt-EV: a framework for standardized reporting of extracellular vesicle flow cytometry experiments

Joshua A. Welsh et al.

JOURNAL OF EXTRACELLULAR VESICLES (2020)

Article Chemistry, Multidisciplinary

Endocytosis of Extracellular Vesicles and Release of Their Cargo from Endosomes

Bhagyashree S. Joshi et al.

ACS NANO (2020)

Article Medicine, Research & Experimental

Successful Transduction with AAV Vectors after Selective Depletion of Anti-AAV Antibodies by Immunoadsorption

Alejandro Orlowski et al.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)

Article Biochemistry & Molecular Biology

Gene therapy for Alzheimer's disease targeting CD33 reduces amyloid beta accumulation and neuroinflammation

Ana Griciuc et al.

HUMAN MOLECULAR GENETICS (2020)

Review Cardiac & Cardiovascular Systems

Current Landscape of Heart Failure Gene Therapy

Jake M. Kieserman et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)

Review Biotechnology & Applied Microbiology

Gene therapy clinical trials worldwide to 2017: An update

Samantha L. Ginn et al.

JOURNAL OF GENE MEDICINE (2018)

Article Medicine, Research & Experimental

Enhanced Production of Exosome-Associated AAV by Overexpression of the Tetraspanin CD9

Lara Timantra Schiller et al.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)

Review Pharmacology & Pharmacy

Exosomes and Exosome-Inspired Vesicles for Targeted Drug Delivery

Sophia G. Antimisiaris et al.

PHARMACEUTICS (2018)

Article Biotechnology & Applied Microbiology

Rescue of Hearing by Gene Delivery to Inner-Ear Hair Cells Using Exosome-Associated AAV

Bence Gyorgy et al.

MOLECULAR THERAPY (2017)

Article Medicine, General & Internal

Gene Therapy in a Patient with Sickle Cell Disease

Jean-Antoine Ribeil et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Medicine, General & Internal

AAV5-Factor VIII Gene Transfer in Severe Hemophilia A

Savita Rangarajan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Biotechnology & Applied Microbiology

Viral vectors for gene therapy and gene modification approaches

Otto-Wilhelm Merten et al.

BIOCHEMICAL ENGINEERING JOURNAL (2016)

Correction Biochemistry & Molecular Biology

Exosome-associated AAV vector as a robust and convenient neuroscience tool (vol 23, pg 380, 2016)

E. Hudry et al.

GENE THERAPY (2016)

Article Biochemical Research Methods

Generation and characterization of anti-Adeno-associated virus serotype 8 (AAV8) and anti-AAV9 monoclonal antibodies

Yu -Shan Tseng et al.

JOURNAL OF VIROLOGICAL METHODS (2016)

Article Multidisciplinary Sciences

An essential receptor for adeno-associated virus infection

S. Pillay et al.

NATURE (2016)

Article Virology

Cellular transduction mechanisms of adeno-associated viral vectors

Garrett Edward Berry et al.

CURRENT OPINION IN VIROLOGY (2016)

Article Cardiac & Cardiovascular Systems

Intracoronary Gene Transfer of Adenylyl Cyclase 6 in Patients With Heart Failure A Randomized Clinical Trial

H. Kirk Hammond et al.

JAMA CARDIOLOGY (2016)

Article Biochemistry & Molecular Biology

Low pH increases the yield of exosome isolation

Jae-Jun Ban et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)

Article Computer Science, Interdisciplinary Applications

Fitting Linear Mixed-Effects Models Using lme4

Douglas Bates et al.

JOURNAL OF STATISTICAL SOFTWARE (2015)

Article Multidisciplinary Sciences

Differential fates of biomolecules delivered to target cells via extracellular vesicles

Masamitsu Kanada et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

Article Multidisciplinary Sciences

Small-molecule activation of SERCA2a SUMOylation for the treatment of heart failure

Changwon Kho et al.

NATURE COMMUNICATIONS (2015)

Article Cell Biology

Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper

Thomas Lener et al.

JOURNAL OF EXTRACELLULAR VESICLES (2015)

Article Biochemistry & Molecular Biology

Expression of sarco (endo) plasmic reticulum calcium ATPase (SERCA) system in normal mouse cardiovascular tissues, heart failure and atherosclerosis

Larissa Lipskaia et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2014)

Article Biochemical Research Methods

Trimmomatic: a flexible trimmer for Illumina sequence data

Anthony M. Bolger et al.

BIOINFORMATICS (2014)

Review Cardiac & Cardiovascular Systems

Exosomes and Cardiac Repair After Myocardial Infarction

Susmita Sahoo et al.

CIRCULATION RESEARCH (2014)

Article Biochemistry & Molecular Biology

Exosome Uptake through Clathrin-mediated Endocytosis and Macropinocytosis and Mediating miR-21 Delivery

Tian Tian et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2014)

Article Biotechnology & Applied Microbiology

Cardiac I-1c Overexpression With Reengineered AAV Improves Cardiac Function in Swine Ischemic Heart Failure

Kiyotake Ishikawa et al.

MOLECULAR THERAPY (2014)

Editorial Material Biotechnology & Applied Microbiology

AAV Empty Capsids: For Better or for Worse?

J. Fraser Wright

MOLECULAR THERAPY (2014)

Article Cardiac & Cardiovascular Systems

Cardiac Surgical Delivery of the Sarcoplasmic Reticulum Calcium ATPase Rescues Myocytes in Ischemic Heart Failure

Anthony S. Fargnoli et al.

ANNALS OF THORACIC SURGERY (2013)

Article Biotechnology & Applied Microbiology

Targeting Sarcoplasmic Reticulum Calcium ATPase by Gene Therapy

Judith K. Gwathmey et al.

HUMAN GENE THERAPY (2013)

Article Biochemistry & Molecular Biology

Exosome Uptake Depends on ERK1/2-Heat Shock Protein 27 Signaling and Lipid Raft-mediated Endocytosis Negatively Regulated by Caveolin-1

Katrin J. Svensson et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2013)

Article Virology

Capsid Antibodies to Different Adeno-Associated Virus Serotypes Bind Common Regions

Brittney L. Gurda et al.

JOURNAL OF VIROLOGY (2013)

Article Multidisciplinary Sciences

A pathogenic picornavirus acquires an envelope by hijacking cellular membranes

Zongdi Feng et al.

NATURE (2013)

Article Multidisciplinary Sciences

Exosome-mediated transmission of hepatitis C virus between human hepatoma Huh7.5 cells

Vedashree Ramakrishnaiah et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Review Biotechnology & Applied Microbiology

Pre-existing Anti-Adeno-Associated Virus Antibodies as a Challenge in AAV Gene Therapy

Vedell Louis Jeune et al.

HUMAN GENE THERAPY METHODS (2013)

Article Cardiac & Cardiovascular Systems

Gene Therapy for Heart Failure: Where Do We Stand?

Charbel Naim et al.

CURRENT CARDIOLOGY REPORTS (2013)

Review Cardiac & Cardiovascular Systems

Modulation of Cardiac Contractility by the Phopholamban/SERCA2a Regulatome

Evangelia G. Kranias et al.

CIRCULATION RESEARCH (2012)

Article Cardiac & Cardiovascular Systems

SERCA2a gene therapy restores microRNA-1 expression in heart failure via an Akt/FoxO3A-dependent pathway

Regalla Kumarswamy et al.

EUROPEAN HEART JOURNAL (2012)

Article Virology

Mapping a Neutralizing Epitope onto the Capsid of Adeno-Associated Virus Serotype 8

Brittney L. Gurda et al.

JOURNAL OF VIROLOGY (2012)

Editorial Material Biotechnology & Applied Microbiology

rAAV-Mediated Tumorigenesis: Still Unresolved After an AAV Assault

Paul N. Valdmanis et al.

MOLECULAR THERAPY (2012)

Article Biotechnology & Applied Microbiology

Neutralizing Antibodies Against AAV Serotypes 1, 2, 6, and 9 in Sera of Commonly Used Animal Models

Kleopatra Rapti et al.

MOLECULAR THERAPY (2012)

Article Biotechnology & Applied Microbiology

Microvesicle-associated AAV Vector as a Novel Gene Delivery System

Casey A. Maguire et al.

MOLECULAR THERAPY (2012)

Article Microbiology

Adeno-Associated Virus 2 Infection Requires Endocytosis through the CLIC/GEEC Pathway

Mathieu Nonnenmacher et al.

CELL HOST & MICROBE (2011)

Article Cardiac & Cardiovascular Systems

Exosomes From Human CD34+ Stem Cells Mediate Their Proangiogenic Paracrine Activity

Susmita Sahoo et al.

CIRCULATION RESEARCH (2011)

Article Multidisciplinary Sciences

SUMO1-dependent modulation of SERCA2a in heart failure

Changwon Kho et al.

NATURE (2011)

Article Biotechnology & Applied Microbiology

SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells

Nicole C. Dubois et al.

NATURE BIOTECHNOLOGY (2011)

Article Biochemistry & Molecular Biology

Near-perfect infectivity of wild-type AAV as benchmark for infectivity of recombinant AAV vectors

N. Zeltner et al.

GENE THERAPY (2010)

Article Biotechnology & Applied Microbiology

A scaling normalization method for differential expression analysis of RNA-seq data

Mark D. Robinson et al.

GENOME BIOLOGY (2010)

Article Immunology

Worldwide Epidemiology of Neutralizing Antibodies to Adeno-Associated Viruses

Roberto Calcedo et al.

JOURNAL OF INFECTIOUS DISEASES (2009)

Article Biotechnology & Applied Microbiology

Ultrafast and memory-efficient alignment of short DNA sequences to the human genome

Ben Langmead et al.

GENOME BIOLOGY (2009)

Review Biochemistry & Molecular Biology

Adeno-associated virus integration: virus versus vector

R. H. Smith

GENE THERAPY (2008)

Article Cardiac & Cardiovascular Systems

Reversal of cardiac dysfunction after long-term expression of SERCA2a by gene transfer in a pre-clinical model of heart failure

Yoshiaki Kawase et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)

Article Virology

Adeno-associated virus vector Genomes persist as episomal chromatin in primate muscle

Magalie Penaud-Budloo et al.

JOURNAL OF VIROLOGY (2008)

Review Biotechnology & Applied Microbiology

Adeno-associated virus: A ubiquitous commensal of mammals

TR Flotte et al.

HUMAN GENE THERAPY (2005)

Article Biotechnology & Applied Microbiology

Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart

Z Wang et al.

NATURE BIOTECHNOLOGY (2005)

Article Virology

Cloning and characterization of a bovine adeno-associated virus

M Schmidt et al.

JOURNAL OF VIROLOGY (2004)

Article Pathology

Myofibroblast and endothelial cell proliferation during murine myocardial infarct repair

JI Virag et al.

AMERICAN JOURNAL OF PATHOLOGY (2003)